in GW, Takase S. Monocyte
inﬁltration into venous valves. J Vasc Surg 1998;27:158-66.
63. Takase S, Pascarella L, Lerond L, Bergan JJ, Schmid-Schönbein GW.
Venous hypertension, inﬂammation and valve remodeling. Eur J Vasc
Endovasc Surg 2004;28:484-93.
64. Mannello F, Raffetto JD. Matrix metalloproteinase activity and glycosaminoglycans in chronic venous disease: The linkage among cell
biology, pathology and translational research. Am J Transl Res
2011;3:149-58.
65. Mannello F, Medda V, Ligi D, Raffetto JD. Glycosaminoglycan
sulodexide inhibition of MMP-9 gelatinase secretion and activity:
Possible pharmacological role against collagen degradation in vascular
chronic diseases. Curr Vasc Pharmacol 2013;11:354-65.
66. Raffetto JD, Qiao X, Koledova VV, Khalil RA. Prolonged increases in
vein wall tension increase matrix metalloproteinases and decrease
constriction in rat vena cava: Potential implications in varicose veins.
J Vasc Surg 2008;48:447-56.
67. Raffetto JD, Ross RL, Khalil RA. Matrix metalloproteinase 2e
induced venous dilation via hyperpolarization and activation of Kþ
channels: Relevance to varicose vein formation. J Vasc Surg 2007;45:
373-80.
68. Raffetto JD, Barros YV, Wells AK, Khalil RA. MMP-2 induced vein
relaxation via inhibition of [Ca2þ]e-dependent mechanisms of venous
smooth muscle contraction. Role of RGD peptides. J Surg Res
2010;159:755-64.
69. Lim CS, Qiao X, Reslan OM, Xia Y, Raffetto JD, Paleolog